Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by MyKnighton Jan 22, 2020 2:27pm

59 Views

Post# 30584487

RE:The world’s largest Gold companies have been busy

Thanks for the tip, but we're already sitting on GOLD mine...

The world’s largest Gold companies have been busy
The world’s largest Gold companies have been busy acquiring rivals within the last year, with Barrick Gold buying Randgold Resources in January and Newmont Mining acquiring Goldcorp in April. So i would say a small capital Gold company will do best especially when we are expecting an increase in Gold Prices. Here is one if you are interested.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario